TANK-binding kinase 1 as a novel therapeutic target for viral diseases

Volume: 23, Issue: 5, Pages: 437 - 446
Published: Apr 10, 2019
Abstract
TANK-binding kinase 1 (TBK1) is vital for the induction of antiviral innate immune responses. Both RNA and DNA viral infection induces TBK1 activation, triggers phosphorylation of interferon regulatory factor (IRF) 3 and subsequent expression of type I interferons (IFNs; IFN-α/β). Type I IFNs can induce the expression of numerous antiviral genes called interferon-stimulated genes (ISGs) to build a remarkable antiviral state and limit viral...
Paper Details
Title
TANK-binding kinase 1 as a novel therapeutic target for viral diseases
Published Date
Apr 10, 2019
Volume
23
Issue
5
Pages
437 - 446
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.